1.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CALGB-90601, CALGB-90601, NCT00942331
|
|
2.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CCC-PHII-75, 7435, NCI-7435, NCT00365157
|
|
3.
|
Phase: Phase II Type: Treatment Status: Active Age: Not specified Sponsor: NCI Protocol IDs: MDA-ID-030111, NCT00082706
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UMCC 2005.145, NCT00393796
|
|
5.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: MAYO-MC0553, 7661, MC0553, NCT00471536
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UMCC 2007.097, NCT00645593
|
|
7.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 2007-0704, NCT00749892
|
|
8.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2007-0933, NCT00756639
|
|
9.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-123, NCT00805129
|
|
10.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-208, NCT00808639
|
|
11.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 06040, NCT00821327
|
|
12.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 06C.549, NCT00437372
|
|
13.
|
Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: 2003-0962, NCT00415675
|
|
14.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: UCSF-08992, 08992, H10778-32056, NCT00911079
|
|
15.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: INST 0813, NCT01010334
|